Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomised, open-label phase III trial to evaluate the efficacy and safety of Bexarotene (TargretinTM) capsules combined with PUVA, compared to PUVA treatment alone in patients with Mycosis Fungoides

Next Previous
Trial Profile

A randomised, open-label phase III trial to evaluate the efficacy and safety of Bexarotene (TargretinTM) capsules combined with PUVA, compared to PUVA treatment alone in patients with Mycosis Fungoides

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 30 May 2019

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bexarotene (Primary) ; Methoxsalen
  • Indications Mycosis fungoides
  • Focus Therapeutic Use

Most Recent Events

  • 30 May 2019 This trial has been completed in Italy, according to European Clinical Trials Database.
  • 30 May 2019 This trial has been completed in Denmark, according to European Clinical Trials Database.
  • 07 Nov 2012 New source identified and integrated (European Clinical Trials Database, EudraCT2004-003701-24).

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top